Nalaganje...
Achieving cancer cell death with PI3K/mTOR-targeted therapies
Inhibitors of the PI3K/mTOR signaling network are under development as novel cancer therapies. However, these compounds do not cause robust cytotoxic responses in tumor cells unless combined with other agents. Rational combinations with other targeted therapies will likely be necessary to achieve th...
Shranjeno v:
| Main Authors: | , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2013
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3621026/ https://ncbi.nlm.nih.gov/pubmed/23551096 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/nyas.12028 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|